Home Study Details

    Program Type

    Home Study


    2 Contact Hour(s)

    Release Date

    Friday, November 16, 2018

    Offline Date

    Sunday, May 16, 2021

    ACPE Expiration Date

    Tuesday, November 16, 2021

    Target Audience




    • Overview

      Influenza (commonly referred to as “the flu”) is a contagious viral infection of the respiratory tract (eg, nose, throat, and lungs). Influenza viruses are primarily spread by respiratory transmission – through droplets from coughing or sneezing. The circulation of influenza viruses varies geographically, with transmission occurring between October and May in the Northern Hemisphere of the temperate region (which includes the US), April and September in the Southern Hemisphere of the temperate region, and year-round in tropical/sub-tropical regions. In the US, peak influenza activity often occurs in January and February. The flu can affect people of all ages, most frequently school aged children, usually causing asymptomatic infection or mild to moderate illness. Severe illness and death occur most often in vulnerable populations (eg, infants, elderly, and immunocompromised individuals). Each year, influenza affects 5-20% of the US population and causes 3,000-49,000 deaths from influenza-related complications. In the 2016-2017 season, 31 million Americans were infected, 14.5 million sought medical care, and 600,000 individuals were hospitalized due to influenza. Influenza vaccination is an important primary prevention strategy. The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination for all persons 6 months and older (unless contraindicated) starting in early fall, as soon as the vaccine becomes available. The vaccine is available in a variety of formulations; however, the ACIP makes no preferential recommendation and encourages vaccination with any licensed, age-appropriate vaccine during the 2018-2019 season. Despite the ACIP’s universal recommendation for influenza vaccination, only 47% of the target population in the US (individuals 6 months and older) received the vaccine during the 2016-2017 season. This issue provides key information on influenza vaccines and antiviral medications for the 2018-2019 flu season, including precautions, side effects, and use in special populations.


      • Homestudy PDF :   18217H07.pdf

      Financial Support By

    • Pharmacist

      Discuss the use of antiviral drugs for influenza treatment and prevention; be able to apply the current recommendations for their use.
      Describe the determinants for influenza vaccine efficacy. Discuss the rationale for the suboptimal efficacy of the 2017-2018 vaccines, and recommendations for the use of LAIV vaccine in 2018-2019.
      Describe the influenza disease course, symptoms, and diagnostic tests. Recognize people at high risk for flu complications.
      State the indications, dosing requirements (children and adults), administration routes, side effects, and contraindications for 2018-2019 influenza vaccinations.
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacist 0798-9999-19-063-H06-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    • Faculty

      Richard  Dang, PharmD, APh, BCACP
      Assistant Professor of Clinical Pharmacy, Director of Student Outreach for Community Health, and Site Coordinator of the PGY-1 Community-Based Pharmacy Residency Program the University of Southern California (USC) School of Pharmacy.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher
    Adobe Acrobat Reader

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).